Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Sanofi Pasteur Ltd. develops, manufactures, and markets vaccines and immunotherapeutic products. It offers vaccines for haemophilus influenza type B (Hib), diphtheria, pertussis, poliomyelitis, tetanus, hepatitis A, influenza, poliomyelitis, rabies, meningococcal disease, typhoid fever, and yellow fever, as well as oncology products for bladder cancers. The company was founded John Gerald FitzGerald in 1914 and is headquartered in Toronto, Canada.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

The Boyce Thompson Institute (previously: Boyce Thompson Institute for Plant Research) is an independent research institute devoted to using plant sciences to improve agriculture, protect the environment, and enhance human health. BTI is located on the campus of Cornell University in Ithaca, New York, United States, and is fully integrated in the research infrastructure of the University. Faculty at BTI are members of several Cornell Departments, including Plant Biology, Chemistry & Chemical Biology, Molecular Biology & Genetics, as well as Plant Pathology and Plant-Microbe Biology. BTI is governed by a Board of Directors, which is in part appointed by Cornell.

BL Corp. engages in the development of biopharmaceutical products. The company operates through the following business divisions: Bio-New Treatment and Product. Its products include poly-y-glutamic acid, lactobacillus plantarum BLS41, and skincare products. The company was founded on December 30, 1999 and is headquartered in Yongin-si, South Korea.

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Anbang (Xiamen) Biotechnology Co., Ltd., established on 2015-07-03, Business scope includes engineering and technology research and experimental development;Manufacturing of chemical preparations;medical diagnosis,Monitoring and treatment equipment manufacturing;second,Wholesale of Class III Medical Devices;second,Retailing of Class III Medical Devices;Other medical equipment and equipment manufacturing;Wholesale of Class I Medical Devices;Retailing of Class I Medical Devices;other computer manufacturing;software development;Information Technology Consulting Services;Other unspecified information technology service industry(Items not subject to permit approval);other internet services(Items not subject to permit approval);Other unlisted professional and technical service industries(Not subject to permit approval);Manage the export business of the company's self-produced products and the machinery and equipment needed by the company,spare parts,Import business of raw and auxiliary materials(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.

Beijing Guoke Rongzhi Biotechnology Co., Ltd., established on 2016-03-04, The scope of business includes the production of medical devices and auxiliary materials;retail medicine;technology development,technology transfer,Technology Promotion,technical consulting,Technical Services;Medical Research and Experimental Development;Import and export;Technology Import and Export;Sell ​​self-developed products;Sales of Class I Class II Medical Devices,Chemical Products(Free of Hazardous Chemicals),Instrumentation,Equipment,Minerals,Chinese herbal medicine.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

MIBR is developing treatments and vaccines for rare diseases, autoimmune diseases, infectious diseases, cancers, etc. novel drug development using artificial intelligence pursuing the goals of developing new drugs and improving public health on a global scale

Zhaoqing Dahuanong Biopharmaceutical Co., Ltd., established on 2002-07-22, The business scope includes the production of veterinary vaccines;sales of veterinary drugs;Technical Services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).The branch produces inactivated embryotoxin vaccines;Sales of veterinary biological products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs, infusions, and artificial kidney dialysis solutions. The Real Estate division handles leasing of real estate properties. The company was founded on March 25, 1937 and is headquartered in Osaka, Japan.

Jilin Teyan Biotechnology Co., Ltd., established on 2009-08-10, Business scope includes veterinary biological products,Research and development of animal health products,technical consulting,Technical Services;Cytotoxic Suspension Culture Live Vaccine Production,Production of live cytotoxic vaccines,Cytotoxic inactivated vaccine production,Bacterial Inactivated Vaccine Production(The veterinary drug production license is valid until2024year1moon7day);Technical consultation on animal disease prevention and control,Technical Services;Enterprises use their own funds to invest abroad(Not to engage in deposit taking,Loans,Entrusted to issue loans,Valet financial,Financing guarantee and other financial services,Illegal fundraising is strictly prohibited);Import and export of goods and technology(Except for publication import business and goods and technologies that are restricted by the state or prohibited from import and export);General cargo(Does not contain flammable, explosive and precursor dangerous chemicals);Feed and Feed Additives,Sales of Veterinary Drugs*(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Tianjin Biochip Technology Co., Ltd., established on 2003-09-26, The scope of business includes the development of biotechnology products,Production,processing,Sales and related technology transfer;Bioinformatics and Biotechnology Consulting,Serve.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Medical University General Hospital (Chinese: 天津医科大学总医院) is a general hospital in the central Heping District of the Chinese metropolis of Tianjin, associated with Tianjin Medical University.

Kyoto Biken Laboratories, Inc. manufactures veterinary vaccines. It specializes in bovine, porcine, poultry, and plant vaccines. The firm��s business activities include research and development, manufacturing, laboratory diagnosis for field specimens, quality control, after sales validation, and packaging and shipment. The company was founded in June 1948 and is headquartered in Uji, Japan.